Literature DB >> 1959027

Brain neuropeptide Y: an integrator of endocrine, metabolic and behavioral processes.

S F Leibowitz1.   

Abstract

Neuropeptide Y (NPY), acting through various medial hypothalamic nuclei, is found to have potent effects on a variety of endocrine, physiological and behavioral systems that modulate energy balance. This peptide affects the release of various hormones, such as corticosterone, insulin, aldosterone and vasopressin, which modulate energy metabolism, as well as food intake. It also has direct impact on energy metabolism through an effect on substrate utilization and lipogenesis. Finally, NPY has a remarkably potent stimulatory effect on feeding behavior, which is characterized by a selective increase in carbohydrate ingestion that is strongest at the beginning of the active feeding cycle and is dependent upon circulating levels of corticosterone. This evidence has led to the proposal that NPY exerts anabolic effects to restore energy balance at specific times of energy depletion. Increased NPY activity may occur at the beginning of the active cycle or after a period of food deprivation. Further evidence, that chronic NPY stimulation produces profound hyperphagia and obesity and that endogenous NPY concentration is increased in genetically obese animals, strongly suggests that hypothalamic NPY may contribute to the development of eating disorders and obesity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1959027     DOI: 10.1016/0361-9230(91)90121-y

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  19 in total

Review 1.  Hypothalamic substrates of metabolic imprinting.

Authors:  Richard B Simerly
Journal:  Physiol Behav       Date:  2007-11-22

2.  Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice.

Authors:  A Kushi; H Sasai; H Koizumi; N Takeda; M Yokoyama; M Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

3.  Circadian integration of sleep-wake and feeding requires NPY receptor-expressing neurons in the mediobasal hypothalamus.

Authors:  M F Wiater; S Mukherjee; A-J Li; T T Dinh; E M Rooney; S M Simasko; S Ritter
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-31       Impact factor: 3.619

4.  Altered gene expression in the host brain caused by a trematode parasite: neuropeptide genes are preferentially affected during parasitosis.

Authors:  R M Hoek; R E van Kesteren; A B Smit; M de Jong-Brink; W P Geraerts
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

5.  Food intake and appetite control in a GH-transgenic zebrafish.

Authors:  Camila Dalmolin; Daniela Volcan Almeida; Marcio Azevedo Figueiredo; Luis Fernando Marins
Journal:  Fish Physiol Biochem       Date:  2015-05-20       Impact factor: 2.794

6.  Analysis of multiple polymorphisms in the bovine neuropeptide Y5 receptor gene and structural modelling of the encoded protein.

Authors:  Tanweer Alam; Bojlul Bahar; Sinéad M Waters; Mark McGee; Torres Sweeney
Journal:  Mol Biol Rep       Date:  2011-09-23       Impact factor: 2.316

7.  Distribution of NPY Y5-like immunoreactivity in the rat brain.

Authors:  S Michelle Morin; Donald R Gehlert
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

8.  Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice.

Authors:  Amanda Sainsbury; Paul A Baldock; Christoph Schwarzer; Naohiko Ueno; Ronaldo F Enriquez; Michelle Couzens; Akio Inui; Herbert Herzog; Edith M Gardiner
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

9.  Central neuropeptide Y and the sigma ligand, JO 1784, reverse corticotropin-releasing factor-induced inhibition of gastric acid secretion in rats.

Authors:  M Gué; M Yoneda; H Mönnikes; J L Junien; Y Taché
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

10.  Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin.

Authors:  A N van den Pol; X B Gao; K Obrietan; T S Kilduff; A B Belousov
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.